台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    79.0
  • 漲跌
    ▼0.5
  • 漲幅
    -0.63%
  • 成交量
    271
  • 產業
    上櫃 生技醫療類股
  • 525人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台康生技 (6589)籌碼相關-元大-雙和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-雙和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/02/2700.00479.5079.00-41,060-0.38%
2025/02/2500.00380.7380.10-31,064-0.28%
2025/02/24382.30281.7081.7011,0660.09%
2025/02/17281.60282.0581.8001,0790.00%
2025/02/14181.5000.0081.9011,0800.09%
2025/02/13281.1000.0080.8021,0910.18%
2025/02/1000.00283.0082.70-21,093-0.18%
2025/02/0700.00182.7083.50-11,116-0.09%
2025/02/0500.00581.1080.90-51,159-0.43%
2025/01/22576.7000.0080.5051,2370.40%
2025/01/2100.00878.8576.30-81,231-0.65%
2025/01/2000.00380.9080.90-31,226-0.24%
2025/01/17480.9000.0081.2041,2500.32%
2025/01/1500.00177.9079.00-11,241-0.08%
2025/01/1400.00279.2078.30-21,236-0.16%
2025/01/103.177.21877.5377.90-4.91,222-0.40%
2025/01/0900.00175.1075.80-11,203-0.08%
2025/01/0600.00274.0074.00-21,188-0.17%
2024/12/3000.00170.8071.50-11,164-0.09%
2024/12/24171.5000.0070.9011,2050.08%
2024/12/1900.00373.3073.10-31,252-0.24%
2024/12/17173.7000.0074.6011,2440.08%
2024/12/1600.00269.6069.50-21,223-0.16%
2024/12/13370.90868.2868.00-51,186-0.42%
2024/12/127.274.1400.0073.507.21,1100.64%
2024/12/119.176.68675.7376.603.11,0450.29%
2024/12/10182.9000.0082.9019450.11%
2024/12/06289.801.389.5890.200.89140.08%
2024/12/05391.9000.0091.5039020.33%
2024/12/0400.00392.8092.30-3899-0.33%
2024/12/03392.2000.0092.2038950.34%
2024/12/0200.001094.5393.30-10876-1.14%
2024/11/2900.00195.4094.20-1845-0.12%
2024/11/271193.022192.8191.10-10797-1.25%
2024/11/19186.6000.0086.6017380.14%
2024/11/14190.1000.0089.0017380.14%
2024/11/12288.5000.0089.4027360.27%
2024/11/11290.8000.0090.7027230.28%
2024/11/08192.00192.8091.7007190.00%
2024/11/071593.1200.0091.70157182.09%
2024/11/06193.8000.0093.1017100.14%
2024/11/05592.7000.0094.1056910.72%
2024/11/0400.00593.3092.60-5690-0.72%
2024/11/01592.1000.0091.8056800.74%
2024/10/3000.00693.0893.00-6658-0.91%
2024/10/29691.88592.5091.6016350.16%
2024/10/28589.70189.9089.5045930.67%
2024/10/2500.00989.6389.10-9594-1.51%
2024/10/2400.00192.3090.90-1594-0.17%
2024/10/2200.00186.5086.60-1566-0.18%
2024/10/1700.00684.5084.50-6613-0.98%
2024/10/14383.77284.1084.4016660.15%
2024/10/11485.3000.0084.5046750.59%
2024/10/09186.7000.0087.3016800.15%
2024/09/30589.3000.0088.8057520.66%
2024/09/26590.082389.6286.20-18861-2.09%
2024/09/25291.50191.1091.1019190.11%
2024/09/24293.7500.0091.5029370.21%
2024/09/23294.00392.9094.00-1937-0.11%
2024/09/19888.16188.1087.9079620.73%
2024/09/18187.70288.8088.80-1962-0.10%
2024/09/04181.5000.0082.9011,2010.08%
2024/09/0200.000.285.2085.10-0.21,212-0.02%
2024/08/28184.9000.0085.1011,2170.08%
2024/08/2600.00184.7084.40-11,226-0.08%
2024/08/2300.00284.6084.60-21,228-0.16%
2024/08/1400.00182.0082.50-11,220-0.08%
2024/08/0900.00280.7080.70-21,227-0.16%
2024/08/0700.00280.9081.10-21,219-0.16%
2024/08/06172.6000.0078.1011,2130.08%
2024/08/05479.83878.5477.30-41,200-0.33%
2024/08/02187.50285.7085.70-11,173-0.09%
2024/07/3100.00188.3087.60-11,162-0.09%
2024/07/3000.00188.1088.10-11,157-0.09%
2024/07/29186.60385.9085.90-21,154-0.17%
2024/07/26188.8000.0088.3011,1470.09%
2024/07/2300.00189.8090.10-11,146-0.09%
2024/07/22290.45289.2589.0001,1440.00%
2024/07/19190.50190.8090.5001,1310.00%
2024/07/1800.00394.2793.40-31,118-0.27%
2024/07/17194.40194.5094.3001,1010.00%
2024/07/16092.8000.0092.7001,0880.00%
2024/07/1200.00091.4091.2001,0680.00%
2024/07/110.191.1000.0090.500.11,0630.01%
2024/07/09191.60190.1091.3001,0840.00%
2024/07/08193.70693.2793.40-51,066-0.47%
2024/07/05192.7200.0093.0011,0540.10%
2024/07/04493.65193.5093.9031,0400.29%
2024/07/03995.38696.1094.9031,0220.30%
2024/07/024.197.41897.9497.10-3.9991-0.39%
2024/07/01992.78195.0096.5088910.90%
2024/06/28389.433.590.3690.50-0.5804-0.06%
2024/06/2700.00689.1088.00-6781-0.77%
2024/06/2600.00389.0390.60-3756-0.40%
2024/06/25185.7000.0085.6016910.14%
2024/06/24587.04187.2086.1046940.58%
2024/06/210.286.20586.1086.60-4.8686-0.70%
2024/06/20285.4000.0086.1026730.30%
2024/06/1900.00184.4083.80-1655-0.15%
2024/06/18786.2000.0085.1076501.08%
2024/06/17285.2000.0085.0026500.31%
2024/06/140.184.6400.0084.000.16430.02%
2024/06/131.183.7100.0083.901.16370.17%
2024/06/124.485.41786.4484.50-2.6622-0.42%
2024/06/11882.81385.6086.3055420.93%
2024/06/07178.000.278.8078.500.84900.16%
2024/06/06178.8000.0078.3014910.20%
2024/06/0500.00179.6080.00-1501-0.20%
2024/06/03279.4500.0079.5025190.39%
2024/05/31279.15179.4080.3015270.19%
2024/05/30179.6000.0079.1015300.19%
2024/05/27179.7000.0079.5015410.18%
2024/05/24279.7500.0079.6025470.37%
2024/05/22180.8000.0080.8015600.18%
2024/05/21181.7000.0081.5015600.18%
2024/05/20182.5000.0082.5015570.18%
2024/05/17183.00182.8083.1005580.00%
2024/05/16181.2000.0081.2015530.18%
2024/05/09080.9000.0080.0005690.00%
2024/05/06080.7000.0080.4006630.00%
2024/05/0300.00081.0080.5006660.00%
2024/04/30581.20181.3081.6046700.60%
2024/04/29580.70179.4081.1046710.60%
2024/04/261078.7900.0078.70106681.50%
2024/04/258.178.8300.0078.708.16711.20%
2024/04/241079.00179.0079.0096741.33%
2024/04/1700.000.181.1081.30-0.1668-0.01%
2024/04/15182.80282.3582.30-1652-0.15%
2024/04/12285.3500.0085.3026390.31%
2024/04/1000.000.286.6086.00-0.2642-0.03%
2024/04/09185.3000.0085.5016440.16%
2024/04/08585.901.186.2285.903.96530.60%
2024/04/0300.00087.0086.4006540.00%
2024/04/021287.3300.0087.10126541.83%
2024/03/29386.4000.0087.0036590.46%
2024/03/2700.00187.9088.20-1662-0.15%
2024/03/260.186.00285.9585.60-1.9661-0.29%
2024/03/25487.7000.0087.4046570.61%
2024/03/20286.50686.0085.90-4667-0.60%
2024/03/1900.00287.0586.90-2656-0.30%
2024/03/18188.20787.8386.90-6653-0.92%
2024/03/15288.50388.4088.40-1650-0.15%
2024/03/130.189.62389.4789.10-2.9659-0.44%
2024/03/1200.00488.5088.70-4648-0.62%
2024/03/111.189.26188.6088.600.16460.01%
2024/03/080.191.0000.0090.600.16400.01%
2024/03/07191.6000.0092.1016420.16%
2024/03/05092.5000.0092.1006390.00%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-2024/12/14
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音